Orthofix Medical Inc
$ 14.05
-2.43%
16 Jan - close price
- Market Cap 556,375,000 USD
- Current Price $ 14.05
- High / Low $ 14.44 / 14.03
- Stock P/E N/A
- Book Value 11.20
- EPS -3.03
- Next Earning Report 2026-02-24
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -0.25 %
- 52 Week High 20.48
- 52 Week Low 10.24
About
Orthofix Medical Inc. (OFIX) is a leading global medical device company based in Lewisville, Texas, focusing on innovative surgical and non-surgical solutions for spine and orthopedic applications. The company maintains a diverse presence in major markets, including the United States, Italy, Germany, the United Kingdom, and Brazil, underscoring its commitment to advancing patient care through state-of-the-art technologies and biopharmaceutical innovations. With a strong emphasis on research and development, Orthofix is well-positioned to address the dynamic requirements of healthcare professionals, thereby enhancing its potential for sustainable growth in the rapidly evolving medical device industry.
Analyst Target Price
$22.80
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-06 | 2025-08-05 | 2025-05-05 | 2025-03-03 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-05 | 2023-11-08 | 2023-08-08 | 2023-05-09 | 2023-03-06 |
| Reported EPS | 0.1976 | -0.36 | -1.3549 | 0.0154 | 0.07 | 0.05 | 0.11 | 0.02 | 0.07 | 0.02 | -0.1 | 0.19 |
| Estimated EPS | -0.3315 | -0.41 | -0.2667 | -0.05 | -0.15 | -0.19 | -0.33 | -0.08 | -0.21 | -0.47 | -0.51 | 0.1 |
| Surprise | 0.5291 | 0.05 | -1.0882 | 0.0654 | 0.22 | 0.24 | 0.44 | 0.1 | 0.28 | 0.49 | 0.41 | 0.09 |
| Surprise Percentage | 159.6078% | 12.1951% | -408.024% | 130.8% | 146.6667% | 126.3158% | 133.3333% | 125% | 133.3333% | 104.2553% | 80.3922% | 90% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-24 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.31 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: OFIX
2026-01-16 10:29:09
Orthofix Medical Inc. (NASDAQ: OFIX) President Massimo Calafiore recently sold US$301k worth of stock at US$15.52 per share, reducing his holding by 19%. While this is the largest insider sale in the past year, it occurred around the current share price of US$14.40, lessening immediate concern. Overall, insider selling has outpaced buying over the last year, and ownership by insiders remains relatively low at 1.2%, suggesting caution for potential investors.
2026-01-15 09:57:09
Orthofix Medical (NASDAQ:OFIX) has experienced significant weakness, with its stock dropping 9.0% this week and accumulating a 68% loss over the past five years. Despite this, the company has seen consistent revenue growth of 17% per year over the last half-decade, which is strong for a pre-profit company. Insiders have also been buying shares, suggesting potential confidence in future performance, though profitability remains a key concern for investors.
2026-01-14 22:58:22
Massimo Calafiore, President and CEO of Orthofix Medical (NASDAQ:OFIX), sold 19,397 shares of company stock across two days in January, totaling approximately $300,955. This transaction leaves him with 217,237 shares directly owned. The sales occurred shortly after the company reported a mixed financial performance for Q3 2025, missing EPS forecasts but exceeding revenue expectations.
2026-01-14 10:28:22
Orthofix Medical President and CEO Massimo Calafiore sold 19,397 shares of company stock for over $300,000 in January. These sales followed the company's Q3 2025 earnings report, which showed a significant EPS miss but exceeded revenue expectations.
2026-01-14 09:59:17
Massimo Calafiore, CEO of Orthofix Medical (NASDAQ:OFIX), sold 9,797 shares of the company's stock on January 12th for approximately $149,012, reducing his stake by 4.32%. The stock was trading down 2.9% at $14.81, with a market capitalization of $586.5 million. Institutional investors own nearly 90% of OFIX, and analysts have a "Moderate Buy" consensus rating with a target price of $21.50.
2026-01-14 09:59:17
Orthofix Medical (NASDAQ:OFIX) CEO Massimo Calafiore sold 9,600 shares of company stock on January 9th for $15.82 per share, totaling $151,872. This transaction, along with a previous sale of 9,797 shares on January 12th, reduced his ownership by 4.06% to 227,034 shares. Analysts currently rate OFIX as a "Moderate Buy" with a consensus target price of $21.50, despite its recent trading performance and various insider and institutional trading activities.
